Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | BMRN | CYTK | ||
| Company | Prometheus Biosciences Inc | Biomarin Pharmaceuticals | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 199.68 | 49.81 | 77.08 | ||
| High | 199.98 | 50.45 | 79.12 | ||
| Low | 199.60 | 49.41 | 76.30 | ||
| Latest | 199.92 | 50.20 | 78.77 | ||
| Change | +0.18 | +0.39 | +2.32 | ||
| % Change | +0.09% | +0.78% | +3.03% | ||
| Volume | 1,860,600 | 2,189,600 | 2,379,500 | ||
| 20-Day Average Volume | 1,174,595 | 2,009,750 | 3,728,850 | ||
| Previous Close | 199.74 | 49.81 | 76.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 53.08 | 71.03 | ||
| 20-Day Raw Stochastic | 99.23% | 11.50% | 93.37% | ||
| 20-Day Relative Strength | 81.45 | 37.28 | 63.66 | ||
| Weighted Alpha | +110.70 | -16.07 | +99.74 | ||
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | -6.26% since 05/13/26 | +2.01% since 05/13/26 | ||
| Low | 198.91 on 06/09/23 | 49.26 on 05/18/26 | 73.00 on 05/19/26 | ||
| High | 199.98 on 06/15/23 | 54.09 on 05/14/26 | 79.12 on 05/20/26 | ||
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | -8.53% since 04/20/26 | +19.10% since 04/20/26 | ||
| Low | 189.76 on 05/16/23 | 49.26 on 05/18/26 | 58.65 on 04/29/26 | ||
| High | 199.98 on 06/15/23 | 57.44 on 05/05/26 | 80.20 on 05/05/26 | ||
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | -21.66% since 02/20/26 | +15.94% since 02/20/26 | ||
| Low | 104.55 on 03/30/23 | 49.26 on 05/18/26 | 58.43 on 03/13/26 | ||
| High | 199.98 on 06/15/23 | 66.28 on 02/24/26 | 80.20 on 05/05/26 | ||
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | -4.34% since 11/20/25 | +24.05% since 11/20/25 | ||
| Low | 103.33 on 01/06/23 | 49.26 on 05/18/26 | 58.43 on 03/13/26 | ||
| High | 199.98 on 06/15/23 | 66.28 on 02/24/26 | 80.20 on 05/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 9,627,476 | 9,512,902 | ||
| Shares Outstanding, K | 47,813 | 193,284 | 124,433 | ||
| Annual Sales | 6,810,000 | 3,221,250,000 | 88,040,000 | ||
| Annual Net Income | -141,750,000 | 348,900,000 | -784,960,000 | ||
| Last Quarter Sales | 1,110,000 | 766,210,000 | 19,360,000 | ||
| Last Quarter Net Income | -40,880,000 | 105,530,000 | -206,030,000 | ||
| 60-Month Beta | -0.49 | 0.23 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 0.76 on 05/04/26 | -1.67 on 05/05/26 | ||
| Earnings Date | 08/10/23 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.47 | 0.00 | ||